<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001790214</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001576885</issuerCik>
      <issuerName>Acumen Pharmaceuticals, Inc.</issuerName>
      <secFileNumber>001-40551</secFileNumber>
      <issuerAddress>
        <com:street1>427 PARK ST.</com:street1>
        <com:city>CHARLOTTESVILLE</com:city>
        <com:stateOrCountry>VA</com:stateOrCountry>
        <com:zipCode>22902</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>925-368-8508</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Zuga Matt</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Officer</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Merrill Lynch</name>
        <address>
          <com:street1>225 Liberty St</com:street1>
          <com:street2>Floor 37</com:street2>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10281</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>4364</noOfUnitsSold>
      <aggregateMarketValue>6986.22</aggregateMarketValue>
      <noOfUnitsOutstanding>60079778</noOfUnitsOutstanding>
      <approxSaleDate>01/21/2025</approxSaleDate>
      <securitiesExchangeName>NASDAQ</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <acquiredDate>01/17/2025</acquiredDate>
      <natureOfAcquisitionTransaction>Vesting of restricted stock unit award</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Acumen Pharmaceuticals, Inc.</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>4364</amountOfSecuritiesAcquired>
      <paymentDate>01/17/2025</paymentDate>
      <natureOfPayment>Granted as part of issuer equity compensation plan</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Matt Zuga</name>
        <address>
          <com:street1>427 PARK ST.</com:street1>
          <com:city>CHARLOTTESVILLE</com:city>
          <com:stateOrCountry>VA</com:stateOrCountry>
          <com:zipCode>22902</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <saleDate>01/03/2025</saleDate>
      <amountOfSecuritiesSold>13235</amountOfSecuritiesSold>
      <grossProceeds>24366.39</grossProceeds>
    </securitiesSoldInPast3Months>
    <noticeSignature>
      <noticeDate>01/21/2025</noticeDate>
      <planAdoptionDates>
        <planAdoptionDate>08/30/2024</planAdoptionDate>
      </planAdoptionDates>
      <signature>Matt Zuga</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
